Related Experiment Video
Updated: Sep 12, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Update of the international multidisciplinary classification of the interstitial pneumonias: an ERS/ATS statement
Christopher J Ryerson1,2, Ayodeji Adegunsoye3,2, Sara Piciucchi4,5,2
1Department of Medicine and Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada chris.ryerson@hli.ubc.ca.
Background:
The 2013 American Thoracic Society/European Respiratory Society statement on the classification of the idiopathic interstitial pneumonias described six major and two rare subtypes of idiopathic interstitial pneumonia, as well as recognising unclassifiable disease.
Objective:
The objective of this statement is to update the 2013 classification of interstitial pneumonia.
Methods:
Five co-chairs identified a committee of 32 experts in the field, as well as two individuals with lived experience. Creation of the document was supported by a series of video meetings, first including the full committee and then subgroups assigned to draft specific sections of the document. The classification scheme was developed by consensus.
Results:
The multidisciplinary committee of experts identified four major advances to the classification of interstitial pneumonia: 1) expansion beyond idiopathic interstitial pneumonias to also include secondary causes; 2) identification of new subcategories and updated terms, including addition of bronchiolocentric interstitial pneumonia as a major pattern as well as changing from acute interstitial pneumonia to idiopathic diffuse alveolar damage and desquamative interstitial pneumonia to alveolar macrophage pneumonia; 3) subclassification of interstitial and alveolar filling disorders, with interstitial disorders further subclassified as fibrotic versus non-fibrotic; and 4) consideration of diagnostic confidence in patient evaluation and management. The committee also provided a comprehensive update on the status of potential molecular tools and identified future research priorities.
Conclusions:
This update builds upon the previous classification approach by describing major advances in the classification of interstitial pneumonia over the past decade.
More Related Videos
05:56Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit
Published on: September 6, 2024
05:50International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure
Published on: March 12, 2020
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Pneumonia II: Pathophysiology